NCT02366325View on ClinicalTrials.gov

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Chronic Renal FailureAnemia
Interventions
DRUG

EPO-018B

Trial Locations (1)

200003

RECRUITING

Changzheng Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY